Company has expanded its biopharmaceutical testing services to include cell-based assays. Company offers assays that examine a variety of endpoints for cellular processes that can be readily applied to the requirements of regulatory testing. These assays examine intracellular processes to obtain high quality safety, potency, toxicity, or ADME data and may be converted to examine the immunogenicity of a therapeutic compound. The company can also assist with method development of cell-based assays as well as cell-line characterization and qualification. Cell-based assays provide clients with relevant information and reduce the time and expense of animal trials. Moreover, the ability to track the behavior of individual cells over time permits data gathering on functional behavior not available in any other kind of assay.

Lancaster Laboratories, Inc.
2425 New Holland Pike, P.O. Box 17605
Lancaster, PA, 17605-2425